235 related articles for article (PubMed ID: 28286253)
41. The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome.
Wang Q; Weisberg E; Zhao JJ
Cell Cycle; 2013 Dec; 12(23):3589-93. PubMed ID: 24131925
[TBL] [Abstract][Full Text] [Related]
42. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome.
Mester JL; Zhou M; Prescott N; Eng C
Urology; 2012 May; 79(5):1187.e1-7. PubMed ID: 22381246
[TBL] [Abstract][Full Text] [Related]
43. Clinical and molecular aspects of PTEN mutations in 10 pediatric patients.
Isik E; Simsir OS; Solmaz AE; Onay H; Atik T; Aykut A; Durmaz A; Cogulu O; Ozkinay F
Ann Hum Genet; 2020 Jul; 84(4):324-330. PubMed ID: 32162695
[TBL] [Abstract][Full Text] [Related]
44. Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer.
Shiovitz S; Everett J; Huang SC; Orloff MS; Eng C; Gruber SB
Breast Cancer Res Treat; 2010 Nov; 124(2):459-65. PubMed ID: 20349131
[TBL] [Abstract][Full Text] [Related]
45. Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience.
Ciaccio C; Saletti V; D'Arrigo S; Esposito S; Alfei E; Moroni I; Tonduti D; Chiapparini L; Pantaleoni C; Milani D
Eur J Med Genet; 2019 Dec; 62(12):103596. PubMed ID: 30528446
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathologic and molecular analysis of a choroidal pigmented schwannoma in the context of a PTEN hamartoma tumor syndrome.
Venturini G; Moulin AP; Deprez M; Uffer S; Bottani A; Zografos L; Rivolta C
Ophthalmology; 2012 Apr; 119(4):857-64. PubMed ID: 22281088
[TBL] [Abstract][Full Text] [Related]
47. An atypical patient with Cowden syndrome and PTEN gene mutation presenting with cortical malformation and focal epilepsy.
Elia M; Amato C; Bottitta M; Grillo L; Calabrese G; Esposito M; Carotenuto M
Brain Dev; 2012 Nov; 34(10):873-6. PubMed ID: 22469695
[TBL] [Abstract][Full Text] [Related]
48. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
[TBL] [Abstract][Full Text] [Related]
49. Skin abnormalities in individuals with macrocephaly: Cowden disease from a dermatologist's point of view.
van der Velden JJ; Vreeburg M; Smeets EE; Schrander-Stumpel CT; van Steensel MA
Int J Dermatol; 2008 Nov; 47 Suppl 1():45-8. PubMed ID: 18986487
[TBL] [Abstract][Full Text] [Related]
50. Thyroid findings in pediatric and adult patients with PTEN hamartoma tumor syndrome: A retrospective analysis, and literature review.
Milani D; Dolci A; Muller I; Pavesi MA; Runza L; Kuhn E; Natacci F; Peissel B; Ricci MT; Despini L; Tomasello G; Grossi F; Garrone O; Gambini D
Endocrine; 2023 Jul; 81(1):98-106. PubMed ID: 36690897
[TBL] [Abstract][Full Text] [Related]
51. Sirolimus treatment of a PTEN hamartoma tumor syndrome presenting with melena.
Şahin GE; Hoşnut FÖ; Yeşil Ş; Lafcı NG; Gül AE; Şahin G
Turk J Pediatr; 2022; 64(4):766-774. PubMed ID: 36082652
[TBL] [Abstract][Full Text] [Related]
52. PTEN hamartoma tumour syndrome: early tumour development in children.
Smpokou P; Fox VL; Tan WH
Arch Dis Child; 2015 Jan; 100(1):34-7. PubMed ID: 25114091
[TBL] [Abstract][Full Text] [Related]
53. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.
Jansen LA; Mirzaa GM; Ishak GE; O'Roak BJ; Hiatt JB; Roden WH; Gunter SA; Christian SL; Collins S; Adams C; Rivière JB; St-Onge J; Ojemann JG; Shendure J; Hevner RF; Dobyns WB
Brain; 2015 Jun; 138(Pt 6):1613-28. PubMed ID: 25722288
[TBL] [Abstract][Full Text] [Related]
54. A family with PTEN mutations with malignancy and an unusually high number of offspring with autism spectrum disorder: a case report.
Gruhl SL; Sharma P; Han TS
J Med Case Rep; 2018 Nov; 12(1):353. PubMed ID: 30482242
[TBL] [Abstract][Full Text] [Related]
55. PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon.
Hopman SM; Van Rijn RR; Eng C; Bras J; Alders M; van der Horst CM; Hennekam RC; Merks JH
Am J Med Genet A; 2012 Jul; 158A(7):1719-23. PubMed ID: 22628360
[TBL] [Abstract][Full Text] [Related]
56. Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study.
Morgan FC; Yehia L; McDonald C; Martinez-Agosto JA; Hardan AY; Tamburro J; Sahin M; Bayart C; Eng C;
J Am Acad Dermatol; 2023 Jul; 89(1):90-98. PubMed ID: 35143913
[TBL] [Abstract][Full Text] [Related]
57. Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome.
Smith JR; Liu E; Church AJ; Asch E; Cherella CE; Srivastava S; Kamihara J; Wassner AJ
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1121-e1130. PubMed ID: 33347563
[TBL] [Abstract][Full Text] [Related]
58. Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.
Hendricks LAJ; Hoogerbrugge N; Venselaar H; Aretz S; Spier I; Legius E; Brems H; de Putter R; Claes KBM; Evans DG; Woodward ER; Genuardi M; Brugnoletti F; van Ierland Y; Dijke K; Tham E; Tesi B; Schuurs-Hoeijmakers JHM; Branchaud M; Salvador H; Jahn A; Schnaiter S; Anastasiadou VC; Brunet J; Oliveira C; Roht L; Blatnik A; Irmejs A; ; Mensenkamp AR; Vos JR
Eur J Med Genet; 2022 Dec; 65(12):104632. PubMed ID: 36270489
[TBL] [Abstract][Full Text] [Related]
59. Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with PTEN hamartoma tumor syndrome.
Liu D; Yehia L; Dhawan A; Ni Y; Eng C
Cell Rep Med; 2024 Feb; 5(2):101384. PubMed ID: 38242121
[TBL] [Abstract][Full Text] [Related]
60. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells.
Chen HH; Händel N; Ngeow J; Muller J; Hühn M; Yang HT; Heindl M; Berbers RM; Hegazy AN; Kionke J; Yehia L; Sack U; Bläser F; Rensing-Ehl A; Reifenberger J; Keith J; Travis S; Merkenschlager A; Kiess W; Wittekind C; Walker L; Ehl S; Aretz S; Dustin ML; Eng C; Powrie F; Uhlig HH
J Allergy Clin Immunol; 2017 Feb; 139(2):607-620.e15. PubMed ID: 27477328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
